Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury
SGLT2 抑制剂恩格列净控制血糖可降低主动脉僵硬程度、肾阻力指数和肾损伤
期刊:Cardiovascular Diabetology
影响因子:8.5
doi:10.1186/s12933-018-0750-8
Annayya R Aroor, Nitin A Das, Andrea J Carpenter, Javad Habibi, Guanghong Jia, Francisco I Ramirez-Perez, Luis Martinez-Lemus, Camila M Manrique-Acevedo, Melvin R Hayden, Cornel Duta, Ravi Nistala, Eric Mayoux, Jaume Padilla, Bysani Chandrasekar, Vincent G DeMarco